Harvest Management’s Apellis Pharmaceuticals APLS Stock Holding History

Harvest Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-70,000	Closed	-$2.82M	–	67
2026 Q1	$2.82M	Buy	+70,000	New	+$1.51M	1.36%	17
2024 Q2	–	Sell	-10,300	Closed	-$605K	–	45
2024 Q1	$605K	Buy	+10,300	New	+$657K	0.41%	32
2023 Q3	–	Sell	-11,000	Closed	-$1M	–	52
2023 Q2	$1M	Buy	+11,000	New	+$949K	0.86%	23

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harvest Management's APLS Position: Q2 2026 in Review

Harvest Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 70,000 shares — an estimated $2.82M sold.

Harvest Management first reported a position in APLS in Q2 2023 and held it in 3 quarters. The position peaked at $2.82M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Harvest Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Harvest Management sold 70,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $2.82M.
Harvest Management first reported a position in Apellis Pharmaceuticals in Q2 2023 and held it in 3 quarters.
Harvest Management's Apellis Pharmaceuticals position peaked at $2.82M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Harvest Management's 13F filing for Q2 2026, filed 14 Aug 2026.